Literature DB >> 27230899

PSP-CBS with Dopamine Deficiency in a Female with a FMR1 Premutation.

Martin Paucar1, Stanislav Beniaminov1, Wojciech Paslawski1, Per Svenningsson2.   

Abstract

Premutations in the fragile X mental retardation 1 (FMR1) gene cause fragile X-associated tremor/ataxia syndrome (FXTAS) and FMR1-related primary ovarian insufficiency (POI). Female FMR1 premutation carriers rarely develop motor features. Dual pathology is an emerging phenomenon among FMR1 premutation carriers. Here, we describe a family affected by FMR1-related disorders in which the female index case has developed a rapidly progressive and disabling syndrome of atypical parkinsonism. This syndrome consists of early onset postural instability, echolalia, dystonia, and varying types of apraxia like early onset orobuccal apraxia and oculomotor apraxia. She has also developed supranuclear gaze palsy, increased latency of saccade initiation, and slow saccades. These features are compatible with progressive supranuclear palsy (PSP) of a corticobasal syndrome (CBS) variant. Imaging displays a marked reduction of presynaptic dopaminergic uptake and cerebrospinal fluid analysis showed reduced dopamine metabolism; however, the patient is unresponsive to levodopa. Midbrain atrophy ("hummingbird sign") and mild cerebellar atrophy were found on brain MRI. Her father was affected by a typical FXTAS presentation but also displayed dopamine deficiency along with the hummingbird sign. The mechanisms by which FMR1 premutations predispose to atypical parkinsonism and dopamine deficiency await further elucidation.

Entities:  

Keywords:  Corticobasal syndrome; Dopamine; FMR1; FXTAS; Fragile X; Progressive supranuclear palsy

Mesh:

Substances:

Year:  2016        PMID: 27230899     DOI: 10.1007/s12311-016-0793-x

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  13 in total

1.  Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X.

Authors:  R J Hagerman; M Leehey; W Heinrichs; F Tassone; R Wilson; J Hills; J Grigsby; B Gage; P J Hagerman
Journal:  Neurology       Date:  2001-07-10       Impact factor: 9.910

2.  Magnetic resonance imaging study in older fragile X premutation male carriers.

Authors:  Danuta Z Loesch; Lucas Litewka; Peter Brotchie; Richard M Huggins; Flora Tassone; Mark Cook
Journal:  Ann Neurol       Date:  2005-08       Impact factor: 10.422

3.  Molecular and imaging correlates of the fragile X-associated tremor/ataxia syndrome.

Authors:  S Cohen; K Masyn; J Adams; D Hessl; S Rivera; F Tassone; J Brunberg; C DeCarli; L Zhang; J Cogswell; D Loesch; M Leehey; J Grigsby; P J Hagerman; R Hagerman
Journal:  Neurology       Date:  2006-10-24       Impact factor: 9.910

Review 4.  The Differential Diagnosis and Treatment of Atypical Parkinsonism.

Authors:  Johannes Levin; Alexander Kurz; Thomas Arzberger; Armin Giese; Günter U Höglinger
Journal:  Dtsch Arztebl Int       Date:  2016-02-05       Impact factor: 5.594

5.  Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS.

Authors:  F Tassone; C M Greco; M R Hunsaker; A L Seritan; R F Berman; L W Gane; S Jacquemont; K Basuta; L-W Jin; P J Hagerman; R J Hagerman
Journal:  Genes Brain Behav       Date:  2012-04-06       Impact factor: 3.449

6.  FXTAS: new insights and the need for revised diagnostic criteria.

Authors:  Emmanuelle Apartis; Anne Blancher; Wassilios G Meissner; Lucie Guyant-Maréchal; David Maltête; Thomas De Broucker; André-Pierre Legrand; Hichem Bouzenada; Hung Tran Thanh; Magali Sallansonnet-Froment; Adrien Wang; François Tison; Carole Roué-Jagot; Frédéric Sedel; Perrine Charles; Sandra Whalen; Delphine Héron; Stéphane Thobois; Alice Poisson; Gaetan Lesca; Anne-Marie Ouvrard-Hernandez; Valérie Fraix; Stephane Palfi; Marie-Odile Habert; Bertrand Gaymard; Jean-Claude Dussaule; Pierre Pollak; Marie Vidailhet; Alexandra Durr; Jean-Claude Barbot; Véronique Gourlet; Alexis Brice; Mathieu Anheim
Journal:  Neurology       Date:  2012-10-17       Impact factor: 9.910

Review 7.  Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome.

Authors:  Randi Hagerman; Paul Hagerman
Journal:  Lancet Neurol       Date:  2013-08       Impact factor: 44.182

8.  Volumetric brain changes in females with fragile X-associated tremor/ataxia syndrome (FXTAS).

Authors:  J S Adams; P E Adams; D Nguyen; J A Brunberg; F Tassone; W Zhang; K Koldewyn; S M Rivera; J Grigsby; L Zhang; C DeCarli; P J Hagerman; R J Hagerman
Journal:  Neurology       Date:  2007-08-28       Impact factor: 9.910

9.  Concomitant fragile X-associated tremor ataxia syndrome and Parkinson's disease: a clinicopathological report of two cases.

Authors:  Eduardo De Pablo-Fernandez; Karen M Doherty; Janice L Holton; Tamas Revesz; Atbin Djamshidian; Patricia Limousin; Kailash P Bhatia; Thomas T Warner; Andrew J Lees; Helen Ling
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-12-04       Impact factor: 10.154

10.  New observations in the fragile X-associated tremor/ataxia syndrome (FXTAS) phenotype.

Authors:  Avram Fraint; Padmaja Vittal; Aimee Szewka; Bryan Bernard; Elizabeth Berry-Kravis; Deborah A Hall
Journal:  Front Genet       Date:  2014-10-17       Impact factor: 4.599

View more
  3 in total

1.  Prosaccade and Antisaccade Behavior in Fragile X-Associated Tremor/Ataxia Syndrome Progression.

Authors:  Yingratana A McLennan; Matthew W Mosconi; Forrest J McKenzie; Jessica Famula; Bennet Krawchuk; Kyoungmi Kim; Courtney J Clark; David Hessl; Susan M Rivera; Tony J Simon; Flora Tassone; Randi J Hagerman
Journal:  Mov Disord Clin Pract       Date:  2022-04-28

2.  Pathological Study of a FMR1 Premutation Carrier With Progressive Supranuclear Palsy.

Authors:  Martin Paucar; Inger Nennesmo; Per Svenningsson
Journal:  Front Genet       Date:  2018-08-15       Impact factor: 4.599

3.  Midbrain atrophy related to parkinsonism in a non-coding repeat expansion disorder: five cases of spinocerebellar ataxia type 31 with nigrostriatal dopaminergic dysfunction.

Authors:  Ryohei Norioka; Keizo Sugaya; Aki Murayama; Tomoya Kawazoe; Shinsuke Tobisawa; Akihiro Kawata; Kazushi Takahashi
Journal:  Cerebellum Ataxias       Date:  2021-03-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.